logo
  

EARNINGS SUMMARY: Details of Nektar Therapeutics Q4 Earnings Report

Below are the earnings highlights for Nektar Therapeutics (NKTR):

-Earnings: -$117.20 million in Q4 vs. -$112.16 million in the same period last year.
-EPS: -$0.65 in Q4 vs. -$0.64 in the same period last year.
-Analysts projected -$0.68 per share
-Revenue: $23.46 million in Q4 vs. $33.86 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT